Explore how cetuximab-conjugated nanoparticles are revolutionizing treatment for triple-negative breast cancer through precision targeting and advanced drug delivery.
Discover how afzelin, a natural plant compound, shows promise in inhibiting triple-negative breast cancer cell migration through reverse docking technology.